Switching to the IL-23 Inhibitor Guselkumab for People With Active IBD Who Previously Used Ustekinumab (SHIFT-IBD)
Switching to the IL-23 Inhibitor Guselkumab for People With Active IBD Who Previously Used Ustekinumab (SHIFT-IBD)
Recruiting · NCT07245394 · Registry updated 2026-08-31Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Switching to the IL-23 Inhibitor Guselkumab for People With Active IBD Who Previously Used Ustekinumab (SHIFT-IBD) | Crohn disease, Digestive System Diseases, colitis, colonic disorder, digestive system disorder, gastroenteritis, inflammatory bowel disease, intestinal disorder, ulcerative colitis | Recruiting | Not stated | 2026-08-31 | NCT07245394 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Janssen Inc. | 6 |
| TIDHI Innovation Inc. | 2 |
14 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Abp Research Services Corporation | Oakville | Canada | 1 |
| Barrie GI Associates | Barrie | Canada | 11 |
| Brampton Gastroenterology Research Group Inc | Brampton | Canada | 1 |
| Centre Hospitalier de l'Université de Montréal (CHUM) | Montreal | Canada | 15 |
| CIUSSS l'Est-de-l'Île-de-Montréal | Montreal | Canada | 1 |
| GNRR Digestive Clinics and Research Center Inc. | Brampton | Canada | 2 |
| Hamilton Health Sciences Corporation | Hamilton | Canada | 1 |
| LDDI Clinical Trials Inc. dba London Digestive Disease Institute | London | Canada | 1 |
| MA MacMillan | Fredericton | Canada | 1 |
| Taunton Surgical Center | Oshawa | Canada | 1 |
| The Research Institute of the McGill University Health Centre | Montreal | Canada | 4 |
| Toronto Immune and Digestive Health Institute | Toronto | Canada | 1 |
| University of Calgary | Calgary | Canada | 31 |
| West Gta Research Inc. | Mississauga | Canada | 1 |